{"name":"ILiAD Biotechnologies","slug":"iliad-biotechnologies","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BPZE1 pertussis vaccine and Boostrix","genericName":"BPZE1 pertussis vaccine and Boostrix","slug":"bpze1-pertussis-vaccine-and-boostrix","indication":"Pertussis (whooping cough) prevention in adolescents and adults","status":"phase_2"}]}],"pipeline":[{"name":"BPZE1 pertussis vaccine and Boostrix","genericName":"BPZE1 pertussis vaccine and Boostrix","slug":"bpze1-pertussis-vaccine-and-boostrix","phase":"phase_2","mechanism":"BPZE1 is a live attenuated pertussis vaccine designed to induce mucosal and systemic immunity against Bordetella pertussis, while Boostrix is a combined acellular pertussis booster vaccine.","indications":["Pertussis (whooping cough) prevention in adolescents and adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQWW80djduSmNQejNyaFNzaFRPMDRnTDFOSnRjZ2JXNnZ0akVTM01BSld1N1hFZk9qT0FZWUpYZ21NOXRjOXVyZ2NCWUdwU1BuNW0xekZjV0JiWjBaMVRhaFotSTNKeXdzemJhdGpvVEYzQWhyaFNsT3pRUURRUWtLTXJ2bGJLUFM1d01GdQ?oc=5","date":"2026-02-13","type":"pipeline","source":"pharmaphorum","summary":"ILiAD bags $115m for pertussis vaccine, and other financings - pharmaphorum","headline":"ILiAD bags $115m for pertussis vaccine, and other financings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQRkdjaHhZdlk5U09GdDhCWVdpbVA3d2hFVmhJRmdiSjQ2M0d3MUlHbnJobHNzcmV0eVFYRWFaQWRHOWI3SGJqeHAtak0tWDAyaEpkcVFqaG9Rbm43SFlfbUxYTlJpeXhCeTZkNzh5V3p3Q1hkMV9MNkdfOW1UNXIxYV8wSHlGQlV6bGJFMDY4cWg1X3RSTHM0dUJuVlF4ODhPcFZZbDhRXzVTRUYxejdmZ05VamJyUGwzdVE?oc=5","date":"2026-02-12","type":"pipeline","source":"Share Talk","summary":"hVIVO Shares Climb 63% Over Two Days Following ILiAD Biotechnologies Series B Funding Round - Share Talk","headline":"hVIVO Shares Climb 63% Over Two Days Following ILiAD Biotechnologies Series B Funding Round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNUUsyUWNaWkJKT0lBMXZKVEVOaGRyZDY0MndxX2lrNi1DQmRnYVozMm5qbWlVTEJrT3FKZnpYNmNzN1BoeEFuNV9IMEE0WS1ySG9xeVU1UkYxbTQyU0E5c3lWempZSXVzaWNvcl80UGFBRHJXemxmaDJlSXZWenZQaVFYQ0o1OU9jaGs4NTVKQlN0cVo1RjhkOFRJeEQ?oc=5","date":"2026-02-11","type":"trial","source":"The Pharma Letter","summary":"ILiAD banks $115m to take vaccine into pivotal study - The Pharma Letter","headline":"ILiAD banks $115m to take vaccine into pivotal study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPQm5rWnVyUkNZNEdXTGNSaUUzbkZVcDNlTmJnME5IZzFhX1k4UkNwWnRMZllOdURvWWNjYlRwOG4yWXQybVpTNEdRckwzY2FORE41TEF2cVFRbTdaWlprZmNlLXUtQlZrLXhhLUt2cXFsb3I2aUxOckxEcVdvV1g1dEVfU2hqTndrSHVhT09nSGtMejJxYzlkdGNEeUpDSUxyRkttNGN2SVdST1pjeHFr?oc=5","date":"2026-02-10","type":"pipeline","source":"Fierce Biotech","summary":"ILiAD Biotechnologies snags $115M series B for whooping cough vaccine - Fierce Biotech","headline":"ILiAD Biotechnologies snags $115M series B for whooping cough vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1JbU5XaWwzekF1NlA4MzN5Q1R5cENoRjIzU09tck1RbmRoSTk3alM1ZWs2RlBSdWZsNl9qRGZNdUdQV05tU2p0TUdnR09UaUZLVlJr?oc=5","date":"2026-02-10","type":"trial","source":"FirstWord Pharma","summary":"ILiAD secures $115M to push intranasal pertussis vaccine to Phase III - FirstWord Pharma","headline":"ILiAD secures $115M to push intranasal pertussis vaccine to Phase III","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPb25OZFVPOUlrWHhuaW1Zd1hfWDFKZHZnWEtBb1Q2ZmNGZlRGZkZlSjk1YkgzVXN2Y1B5ZEIyOEJfTzJkZkpmLV9yMkdHZEZZMXBZVzJuSWRuQVpHSnFONzhKZEpfRHFiV05ETVhiNlh0SE4zWVJlNnJiVDV2eGFKRW1rQnJsdnQ1Y1YxbmlWTmMwb3lpanpLYlQzV3h2ZExVSzRMYk1nRk5LbFpiaXpVT0NoYWpDU1RtdXZ1c2haZWJjMnF3OVFTOUhvNVRwVTVsc0tGdmlHYVRRcU00enpfUnZCTGotYVAtQ2p5N0pYc2czV1VpUmg1bg?oc=5","date":"2026-02-10","type":"pipeline","source":"Business Wire","summary":"ILiAD Biotechnologies Announces $115M Oversubscribed Series B Financing to Advance BPZE1 Pertussis Vaccine - Business Wire","headline":"ILiAD Biotechnologies Announces $115M Oversubscribed Series B Financing to Advance BPZE1 Pertussis Vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxOcFQ1Mm9NbUN1dUlOODEzZ0xUeVQ4V1RBZlBOTDhFRW9vQlk3cm42MFhKNmFBWXFJWVZ5UFpoVHBrY3NQcHA3cVNHR2pjbUVUX2hjSVRJTUF2NmxpNXkxWGtiWG95SGl2eWtrbldzbm0wZTZXWXBTOU04Y2J2YzlkY2VFU2xzc3V6aVk3a3hZakJVOVM3N2J1bThOdzgzVWNVa3FxTEtZSWJTbjQ5TkxUeldaMWk3Nnp0ek1UeDUyM3NLRVB0WmRjRlhESmNSWlZUM3VvLTBndzV2d3NCZmtGLU1sR3ZJaHhaUWJzQXRZU19qaHkyRFBfMnVmZ3NLTGI4dWRTZE1R?oc=5","date":"2025-12-02","type":"trial","source":"Business Wire","summary":"ILiAD Biotechnologies Announces Lancet Microbe Publication of BPZE1 Phase 2b Clinical Results in Human Challenge Model - Business Wire","headline":"ILiAD Biotechnologies Announces Lancet Microbe Publication of BPZE1 Phase 2b Clinical Results in Human Challenge Model","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPM1VjeVQyZlBCSHhIN0MyNEN1Zk1hVWRveUFRUmwtZW02YVdYUUR3eDRvamJ5Vndxb3lMMFIzZlBsSnNvQUtlR0o3d0dQWnZNUE5FZzhPOVVwS2VEcGhza1U1SHo2NGI3WDBsMjg1T0ZTN3lJU0hZVjNjU20zQkJkZXBCd3JQVkxFa1NBb0VEY19YcXpBOVRhZUgxVHZoOXl2eFFHY0ZZOU1RWHJVWGxYVVhyQ0ZITEgxSGpUeGloVzJFczRGTm9zWVZfSnRJVUVpUm9LdFNR?oc=5","date":"2025-01-27","type":"regulatory","source":"BioSpace","summary":"ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting - BioSpace","headline":"ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPaFAydmJzVDhXZWhKODVLT1VVQ05aWmFrTGpITktiRHN6YTFLaVpVNkRrZV9XNm5jeGg0NFI3LS15S0VzMHQ2ZDRucWh3dUJ3ZlZwUm5PdndCMHZHRGxTZDVfU25uLU16UVVydlQ1Nkx2MU0zd0FoMUd6MkVEdnlFeGlWU2dZRHJiRmc2U2M2eEpVYWZhSkF6aTF3?oc=5","date":"2025-01-03","type":"pipeline","source":"Fierce Biotech","summary":"Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders - Fierce Biotech","headline":"Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOOWFfYnFJZmxoQXEtWW9wMHB0QS1RZE50SDJkck56SGxjQ0ptQ1dMbjJTR3hJYjltQWM0RjFiTHZEemdjTG1MRi1nYWlTcXk0WXlXSVRRNnJhbDZrU2ltQnZkNWYzYjRYbmtKUUUxVG1fM3Jwdm1EOTFkeEtGNlQ4R2w5YTZ1UEJrUVBzUHpwVjNNZG1QYjhfNTRZWGdtUTBscmxQa0ZLZmxhSzlhcXY2eDhn?oc=5","date":"2024-12-05","type":"trial","source":"The Clinical Trial Vanguard","summary":"Iliad Biotech’s Intranasal Pertussis Vaccine Gets Innovation Passport - The Clinical Trial Vanguard","headline":"Iliad Biotech’s Intranasal Pertussis Vaccine Gets Innovation Passport","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOZFdTbDBWcHdXcXBRTzN0VmFjMkxjYTV0b0RvdjlHVERRLV83YVB0eGtkUUlyMDlhRmxPQjRQRldvdnA0QTZPTkhJYkhvVmQ5NnhXRXd2N2duQlVCQUdCbzBlNlZZUk9Kb0xIVVY5ZkN5WGcxUlpFSHBYS2ltcnlMVnNsVnd5WFl6SnptME1hdTN2ajdNVFVJSUljRjRfLVJSSU0tWUl4ZWlOV212ejBIMFotbnFzdFZhY2lyckUtRmE?oc=5","date":"2024-08-05","type":"pipeline","source":"CRISPR Medicine News","summary":"Press Release Service: Fierce Biotech Names ILiAD Biotechnologies to its 2024 Fierce 15 - CRISPR Medicine - CRISPR Medicine News","headline":"Press Release Service: Fierce Biotech Names ILiAD Biotechnologies to its 2024 Fierce 15 - CRISPR Medicine","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-06-25","type":"trial","source":"ET HealthWorld","summary":"Emmes Group to conduct Phase III studies of ILiAD Biotechnologies pertussis vaccine candidate, BPZE1 - ET HealthWorld","headline":"Emmes Group to conduct Phase III studies of ILiAD Biotechnologies pertussis vaccine candidate, BPZE1","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}